Investigating islet cell infusion in people with type 1 diabetes and kidney transplant
The purpose of this study is to test whether an investigational infusion of islet cells (called VX-880) would be safe, tolerable and effective in providing better control of blood sugar levels for patients with type 1 diabetes who have a kidney transplant.
Status
Recruiting